ProKidney advances to late-stage trial, widens Q1 loss to $42.6M on pivotal study ramp-up
Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 12, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade PROK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 4:13 PM